{
    "Clinical Information": [],
    "Patent Information": [
        {
            "Patent No": "US 2023/0416797 A1",
            "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
            "Patent Type": "Patent Application",
            "Publication Date": "2023-12-28",
            "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
            "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
            "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
        }
    ],
    "Sequence Information": {
        "DRAMP ID": "DRAMP00056",
        "Peptide Name": "Bacteriocin ancovenin",
        "Source": "Streptomyces sp. A647P-2 (Gram-positive bacteria)",
        "Family": "Belongs to the type B lantibiotic family (Class I bacteriocin)",
        "Gene": "Not found",
        "Sequence": "CVQSCSFGPLTWSCDGNTK",
        "Sequence Length": "19",
        "UniProt Entry": [
            "http://www.uniprot.org/uniprot/P38655"
        ],
        "Protein Existence": "Protein level",
        "Biological Activity": [
            "Antimicrobial"
        ],
        "Target Organism": "No MICs found in DRAMP database",
        "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
        "Cytotoxicity": "Not included yet",
        "Binding Target": "Not found",
        "Linear/Cyclic": "Not included yet",
        "N-terminal Modification": "Not included yet",
        "C-terminal Modification": "Not included yet",
        "Nonterminal Modifications and Unusual Amino Acids": "Not included yet",
        "Stereochemistry": "Not included yet",
        "Structure": "Not found",
        "Structure Description": "Not found",
        "Helical Wheel Diagram": "",
        "PDB ID": "None",
        "Predicted Structure": "There is no predicted structure for DRAMP00056.",
        "Formula": "C85H129N23O29S3",
        "Absent Amino Acids": "AEHIMRY",
        "Common Amino Acids": "CS",
        "Mass": "2033.28",
        "PI": "5.82",
        "Basic Residues": "1",
        "Acidic Residues": "1",
        "Hydrophobic Residues": "4",
        "Net Charge": "0",
        "Boman Index": "-21.8",
        "Hydrophobicity": "-0.168",
        "Aliphatic Index": "35.79",
        "Half Life": "Mammalian:1.2 hourYeast:>20 hourE.coli:>10 hour",
        "Extinction Coefficient Cystines": "5625",
        "Absorbance 280nm": "312.5",
        "Polar Residues": "11",
        "MOA": "Acts as an inhibitor of angiotensin I converting enzyme.",
        "PTM": "Maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine or the formation of dialkylamine bonds with lysine. This is followed by membrane translocation and cleavage of the modified precursor.",
        "Literature": [
            {
                "Title": "The structure of ancovenin, a new peptide inhibitor of angiotensin I converting enzyme.",
                "Pubmed ID": "PubMed ID is not available",
                "Reference": "Tetrahedron Lett. 1985;26665-668.",
                "Author": "Wakamiya T, Ueki Y, Shiba T, Kido Y, Motoki Y.",
                "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=PubMed ID is not available"
            }
        ],
        "3D_Structures": []
    }
}